Grail stock surges after Samsung announces $110 million investment

Published 16/10/2025, 13:34
© Reuters.

Investing.com -- Grail Inc (NASDAQ:GRAL) stock jumped 14.5% in premarket trading Thursday after Samsung C&T and Samsung Electronics announced plans to invest $110 million in the cancer detection company.

The investment, priced at $70.05 per share of common stock, comes as part of a strategic collaboration to bring Grail’s Galleri multi-cancer early detection test to key Asian markets. The companies signed a binding Letter of Intent that will see Samsung C&T drive commercialization of the test in South Korea, with potential expansion to Japan and Singapore.

Under the agreement, Samsung C&T will work as Grail’s exclusive partner to commercialize the Galleri test in South Korea initially, with tests performed at Grail’s clinical laboratory in North Carolina. The companies plan to negotiate definitive agreements in early 2026, with commercial operations beginning shortly after execution.

"Samsung’s significant equity investment strengthens our balance sheet and provides further cash runway as we advance through key milestones to secure reimbursement for Galleri in the U.S. and key international markets," said Sir Harpal Kumar, President of International Business & Biopharma at Grail .

The collaboration also includes plans for Samsung Electronics and Grail to explore potential strategic and operational partnerships, including supporting genomic-lifestyle clinical research and integrating Samsung’s health data platform with Grail’s technologies.

The investment is subject to execution of definitive collaboration agreements and customary closing conditions, with an expected closing in early 2026.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.